Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Small Cell Lung Cancer
Interventions: topotecan/cisplatin, etoposide/cisplatin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 66
States / cities: Hoover, Alabama • Chula Vista, California • Fountain Valley, California + 57 more

Conditions: Influenza, COVID-19 (Coronavirus Disease 2019)
Interventions: Investigational Influenza Vaccine, Investigational COVID-19 Vaccine, Investigational Influenza and COVID-19 Combination Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Licensed Influenza Vaccine 3, Licensed COVID-19 Vaccine; Biological · Combination Product
Lead sponsor: BioNTech SE; Industry
Eligibility: 18 Years and older
Enrollment: 2,650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 31
States / cities: Anaheim, California • Lake Forest, California • Riverside, California + 26 more

Conditions: Diabetes Mellitus, Type 1
Interventions: SteadiSet Infusion Set; Device
Lead sponsor: Tandem Diabetes Care, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obstructive Sleep Apnea Syndrome, Cleft Lip/Palate
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 1 Year to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Breast Cancer
Interventions: exemestane, Placebo; Drug
Lead sponsor: NCIC Clinical Trials Group; Network
Eligibility: Up to 120 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2009
U.S. locations: 8
States / cities: Jacksonville, Florida • Boston, Massachusetts • Rochester, Minnesota + 2 more

Conditions: Group B Streptococcus Infections
Interventions: Multivalent Group B streptococcus vaccine, Tetanus, diphtheria, and acellular pertussis vaccine, Placebo; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 12
States / cities: Newton, Kansas • Omaha, Nebraska • Las Vegas, Nevada + 8 more

Conditions: Healthy, Inflammation
Interventions: etanercept (Enbrel); Drug
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: Not listed
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cystic Fibrosis
Interventions: Placebo, Tobi Podhaler; Drug · Device
Lead sponsor: Mylan Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 9
States / cities: Miami, Florida • Orlando, Florida • Pensacola, Florida + 4 more

Conditions: Schizophrenia
Interventions: BI 409306 100 mg QD, BI 498306 50 mg QD, Placebo, BI 498306 25 mg QD, BI 409306 10 mg QD; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 24
States / cities: Little Rock, Arkansas • Cerritos, California • Garden Grove, California + 18 more

Conditions: Phobic Disorders
Interventions: Escitalopram; Drug
Lead sponsor: Connor, Kathryn M., M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Sarcoma, Kaposi, HIV Infections
Interventions: Interleukin-4; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1998
U.S. locations: 3
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Dyspnea, Acute Heart Failure Syndrome, Pulmonary Congestion
Interventions: IMED-4; Device
Lead sponsor: Intersection Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 3
States / cities: Boston, Massachusetts • Detroit, Michigan • Columbus, Ohio

Conditions: Acute Kidney Injury, Kidney; Disease, Acute, Dialysis Related Complication
Interventions: Dialysis; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: San Francisco, California • St Louis, Missouri • Nashville, Tennessee + 1 more

Conditions: Pediatric Cancer, Nutrition Related Cancer, Nutrition Aspect of Cancer, Muscle Loss, Malnutrition, Child
Interventions: Oral Nutrition Supplement, Tube Feed, Cyproheptadine, Olanzapine, Standard of Care; Dietary Supplement · Drug · Other
Lead sponsor: Corey Hawes; Other
Eligibility: 2 Years to 19 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 18 Years and older
Enrollment: 7,776 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2009
U.S. locations: 7
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • New Orleans, Louisiana + 4 more

Conditions: Severe Aplastic Anemia, Very Severe Aplastic Anemia, Moderate Aplastic Anemia
Interventions: Eltrombopag; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Sleep Apnea, Obstructive
Interventions: Heated breathing tube (CPAP with ThermoSmart), Non heated breathing tube (CPAP with conventional humidification); Device
Lead sponsor: Fisher and Paykel Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 2
States / cities: Tulsa, Oklahoma

Conditions: Physical Inactivity
Interventions: The Rising New York Road Runners program; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID-19
Interventions: abatacept infusion, Placebo group; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 82
States / cities: Birmingham, Alabama • Tucson, Arizona • Davis, California + 58 more

Conditions: PTSD, Overweight, Obesity
Interventions: MOVE!+UP, MOVE!; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Human Immunodeficiency Virus
Interventions: Silicone Elastomer Vaginal Ring, Female Condom; Combination Product · Device
Lead sponsor: International Partnership for Microbicides, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV/AIDS, Cancer
Interventions: Culturally-tailored cognitive behavioral stress management; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Age-Related Macular Degeneration, Macular Degeneration
Interventions: Intravitreal Aflibercept Injection; Drug
Lead sponsor: MidAtlantic Retina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Cherry Hill, New Jersey • Huntingdon Valley, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Endometrial Cancer
Interventions: Gemcitabine, Cisplatin; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 3
States / cities: Houston, Texas

Search by objective public record fields.

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/Palate

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction

Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules

A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

Study of Escitalopram in the Treatment of Specific Phobia

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

Precision of IMED-4 Lung Fluid Measurements

Liberation From Acute Dialysis

Pediatric Oncology Nutrition Intervention Trial

Genetic Analysis of Hereditary Prostate Cancer

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification

Supporting Physical Literacy at School and Home

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD

A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring

Web-Based Cognitive Behavioral Stress Management for Latino Sexual Minority Men Living With HIV and Cancer

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer